HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Phase II study of carbetimer in non-small cell lung cancer.

AuthorsM Keaton, T Brown, J Craig, G Fries, G Harmon, A Zaloznik, G Orczyk, D Von Hoff
JournalInvestigational new drugs (Invest New Drugs) Vol. 8 Issue 4 Pg. 385-6 (Nov 1990) ISSN: 0167-6997 [Print] United States
PMID1964676 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Drugs, Investigational
  • Polymers
  • carboxyimamidate
Topics
  • Adult
  • Aged
  • Antineoplastic Agents (adverse effects, therapeutic use)
  • Carcinoma, Non-Small-Cell Lung (drug therapy)
  • Drug Evaluation
  • Drugs, Investigational (adverse effects, therapeutic use)
  • Female
  • Humans
  • Lung Neoplasms (drug therapy)
  • Male
  • Middle Aged
  • Polymers (adverse effects, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: